SAVVY® (C31G) Gel for Prevention of HIV infection in Women: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Ghana

OBJECTIVE: The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk. METHODOLOGY/PRINCIPAL FINDINGS: This was a Phase 3, double-blind, randomized, placebo-controlled trial. Particip...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Leigh, Nanda, Kavita, Opoku, Baafuor Kofi, Ampofo, William Kwabena, Owusu-Amoako, Margaret, Boakye, Andrew Yiadom, Rountree, Wes, Troxler, Amanda, Dominik, Rosalie, Roddy, Ronald, Dorflinger, Laneta
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2129116/
https://www.ncbi.nlm.nih.gov/pubmed/18091987
http://dx.doi.org/10.1371/journal.pone.0001312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2129116/
https://www.ncbi.nlm.nih.gov/pubmed/18091987
http://dx.doi.org/10.1371/journal.pone.0001312

Ejemplares similares